Antidepressant Drug Claim and Suicide Claims (Adverse Drug Reactions)
Antidepressant Drugs can be used to treat people with depression. However, in some people, incorrect treatment with certain types of antidepressant drugs can cause suicidal thinking or actions or make a depressed person worse. Deciding on whether a person should be placed on certain types of antidepressants should be a team decision including the doctor, the patient, and a patient's parents or guardians if the depressed person is a minor. The team should discuss all treatment choices, including the potential dangers of using antidepressants including suicide and birth defects in pregnant women.
If someone you love has been treated with antidepressants and that treatment has resulted in suicide, feel free to submit an inquiry or send an e-mail to Texas Antidepressant Claim lawyer Jason Coomer. He may be able to help you investigate the suicide and determine if the antidepressant medication treatment the person was receiving was proper.
The Food and Drug Administration (FDA) has asked manufacturers of all antidepressant drugs to include in their labeling a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality (suicidal thinking and behavior) in children and adolescents being treated with these agents, and additional information about the results of pediatric studies. The study reviewed five selective serotonin reuptake inhibitors (SSRIs) (Celexa, Prozac, Luvox, Paxil and Zoloft) and four "atypical" antidepressants (Wellbutrin, Remeron, Serzone and Effexor XR).
Of all antidepressants, only fluoxetine (brand name: Prozac) has been FDA approved to treat pediatric depression. For obsessive compulsive disorder, FDA considers only fluoxetine (brand name: Prozac), sertraline (brand name: Zoloft), fluvoxamine (no marketed brand name product), and clomipramine (brand name: Anafranil) to be of proven benefit in children and teens. The past experiences of the patient with other treatments or antidepressants may lead the doctor to suggest other antidepressants than the ones listed above. However, make sure everyone understands the potential risks of using antidepressants to treat pediatric depression. Mirtazapine (marketed as Remeron and Remeron Soltab) have been linked with suicidal thoughts in adults and teenagers.
Nefazadone hydrochloride (marketed as
Serzone and Nefazodone HCL) is another SSRI that is
prescribed for patients experiencing depression or mental
illness. The FDA also administered a black-box warning for
Serzone, claiming it increased the thoughts and attempts of
suicide in children and adults taking the drug.
Bupropion hydrochloride (marketed as Wellbutrin, Wellbutrin SR/XL and Zyban) has also drawn the FDA’s attention lately. This antidepressant is believed to be related to increased thoughts and attempts of suicide among children and adults taking the drug.
Additionally, regulatory authorities in the United Kingdom (U.K.) have announced new labeling for the antidepressant drug Effexor (venlafaxine) and antidepressant drugs known as SSRIs (selective serotonin reuptake inhibitors). For Effexor and the SSRIs, the British authorities strengthened warnings about
suicidal thoughts and behaviors
certain withdrawal effects
For Effexor, they announced that patients with heart disease or high blood pressure should not use the drug. The authorities will only allow certain physician specialists to prescribe the drug.
Paxil (paroxetine) is one of a class of medicines called Selective Serotonin Reuptake Inhibitors (SSRIs). These drugs increase the activity of an important brain chemical called serotonin, a chemical know to be deficient in patients with MDD.
The FDA has not approved Paxil for the treatment of MDD or any other indication in pediatric patients. However, the FDA does not regulate the practice of medicine and physicians may use a drug in ways other than indicated on the labeling when, in their professional judgment, if it is warranted in a particular case. This is based on three well-controlled clinical trials carried out in children (under 18 years of age) with MDD that compared the effect of Paxil and placebo (sugar pills) and found that Paxil did not work any better than placebo in the treatment of MDD. In fact, based on the results of the analyses of safety data from pediatric studies, it was found that certain suicide-related behaviors, including suicidal thoughts and attempts, were more common in children receiving Paxil. The risk of these events in the study was about 3 times greater with Paxil compared to placebo. There were no deaths in these trials.
If any of the following behaviors appear for the first time or seem worse after starting a new antidepressant medication, a medical professional should be contacted right away.
New or more thoughts of suicide
Trying to commit suicide
New or worse depression
New or worse anxiety
Feeling very agitated or restless
Difficulty sleeping (insomnia)
New or worse irritability
Acting aggressive, being angry, or violent
Acting on dangerous impulses
Being extremely hyperactive in actions and talking (hypomania or mania)
Other unusual changes in behavior
If someone you love is suffering from depression, make sure you have all the facts and have carefully weighed your options prior to selecting an antidepressant. If a suicide has occurred and you believe that there was an improper treatment or incorrect treatment, contact Austin Antidepressant lawyer, Jason S. Coomer. He helps individuals that have lost a loved one from improper doses or treatment from antidepressants investigate suicide claims. If you have lost a loved one from psychiatric malpractice or improper antidepressant medication, contact Austin Texas Psychiatrist Malpractice Lawyer Jason Coomer.
He works with other Texas Psychiatrist Malpractice Lawyers including Houston psychiatrist malpractice lawyers, Dallas Psychiatrist Malpractice Lawyers, San Antonio Psychiatrist Malpractice Lawyers, and other Austin Psychiatrist Negligence Lawyers on a variety of psychiatrist malpractice claims.